Spyre Therapeutics, Inc.

The momentum for this stock is not very good. Spyre Therapeutics, Inc. is not a good value stock. Spyre Therapeutics, Inc. is not a good growth stock. Spyre Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Spyre Therapeutics, Inc..

News

Spyre Therapeutics to Participate in Upcoming Investor Conference

PR Newswire Spyre Therapeutics to Participate in Upcoming Investor Conference Spyre Therapeutics to Participate in Upcoming Investor Conference PR Newswire WALTHAM, Mass., Sept. 10, 2024 WALTHAM, Mass., Sept...\n more…

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Forecasted to Earn Q3 2024 Earnings of ($0.45) Per Share

Ticker Report Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) - Equities researchers at Wedbush issued their Q3 2024 earnings estimates for shares of Spyre Therapeutics in a research report issued on Tuesday...\n more…

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Forecasted to Earn Q3 2024 Earnings of ($0.45) Per Share

Zolmax Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) - Investment analysts at Wedbush issued their Q3 2024 earnings per share estimates for shares of Spyre Therapeutics in a research note issued on...\n more…

Spyre Therapeutics files for $500M mixed securities shelf

SeekingAlpha.com: All News Spyre Therapeutics (SYRE) filed for a $500M mixed securities shelf, indicating potential upcoming offerings to raise capital for the company.\n more…

Spyre Therapeutics files $500M mixed securities shelf

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Spyre Therapeutics (NASDAQ:SYRE) Shares Gap Up to $26.60

Ticker Report Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report)'s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $26.60, but opened at $27.14. Spyre Therapeutics...\n more…